Trial Outcomes & Findings for Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies (NCT NCT01553240)

NCT ID: NCT01553240

Last Updated: 2017-01-13

Results Overview

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

8 participants

Primary outcome timeframe

during screening

Results posted on

2017-01-13

Participant Flow

P.I. has left the institution and NYSPI has no access to the data. Results will not be analyzed or presented.

Participant milestones

Participant milestones
Measure
TMS and fMRI
* functional MRI * single and paired pulse TMS (to identify the difference of motor excitability between patients and healthy controls) TMS and functional MRI (Magstim): single and paired pulse low frequency TMS. 3T structural MRI scans, amplitude modulated continuous arterial spin labeling( CASL) perfusion imaging sequence optimized for 3T is employed for perfusion MR scans using GE FAIR sequence for parallel imaging.
Overall Study
STARTED
0
Overall Study
COMPLETED
0
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: during screening

Population: P.I. has left the institution and NYSPI has no access to the data. Results will not be analyzed or presented.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: during screening

Population: P.I. has left the institution and NYSPI has no access to the data. Results will not be analyzed or presented.

Outcome measures

Outcome data not reported

Adverse Events

TMS and fMRI

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Linda Sherman

New York State Psychiatric Institute

Phone: (646) 774-7158

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place